Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Clin Cancer Res. 2017 Jan 13;23(9):2136–2142. doi: 10.1158/1078-0432.CCR-16-0934

Figure 1.

Figure 1

Targeting molecular pathway. Activation of oncogenic PTPs, (SHP2, PTP1B and PTP4A3) by growth factor receptors promotes tumorigenesis, growth, survival and metastasis through activating Ras/raf/MAPK and PI3K/Akt pathways in several human cancers. Targeting these phosphatases reduces the tumor formation, growth, survival and metastatic potential.